SEC Form 4 research
| Issuer | Obsidian Therapeutics, Inc. |
|---|---|
| Tickers | OBX |
| Reporting owners | 8 |
| Officers and directors | 0 |
| Last public filing | 2026-08-06 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-08-05 | 2026-08-03 | ROSS ROBERT W. | A | 37,653 | $0 | Not reported |
| 2026-08-05 | 2026-08-03 | Norkunas Matthew | A | 37,653 | $0 | Not reported |
| 2026-08-05 | 2026-08-03 | Jagasia Madan | A | 37,653 | $0 | Not reported |
| 2026-08-05 | 2026-08-03 | Barrett Peter | A | 37,653 | $0 | Not reported |
| 2026-08-05 | 2026-08-03 | Hagen Heidi | A | 37,653 | $0 | Not reported |
| 2026-08-05 | 2026-08-03 | Fardis Maria | A | 37,653 | $0 | Not reported |
No directory officers or directors published yet.
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.